Acutus Medical to Present at the J.P. Morgan 39th Annual Healthcare Conference – Stocks News Feed

Monday, 28 December 2020, 22:45:00
CARLSBAD, Calif., Dec. 28, 2020 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced that its management will present at the upcoming J.P. Morgan 39th Annual Healthcare Conference on Wednesday, January 13, 2021 at 10:00 a.m. Eastern Time.… Read More »Acutus Medical to Present at the J.P. Morgan 39th Annual Healthcare Conference
— Stocks News Feed

Acutus Medical reports $3.2M in Q3 sales, installed base gains

Friday, 13 November 2020, 19:00:00
Acutus Medical Inc. posted strong results for the third quarter of 2020, despite the ongoing uncertainties of the COVID-19 pandemic. Sales for the quarter totaled $3.2 million, up 180% sequentially and 391% when compared with the same period in 2019. Driving the increase were direct sales of Acutus disposables, sales of Acqmap consoles and distributor sales via partner Biotronik Inc., the company said. Carlsbad, Calif.-based Acutus, which focuses on cardiac electrophysiology (EP), made its Wall Street debut in August. During the quarter, Acutus expanded its . . .
— BioWorld

Acutus Medical to Announce Third Quarter 2020 Financial Results

Thursday, 29 October 2020, 21:01:00
CARLSBAD, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), today announced it will release its financial results…
— GlobeNewswire

Acutus Medical, Inc. (NASDAQ:AFIB) Receives $38.75 Average PT from Analysts

Friday, 23 October 2020, 16:19:09
Shares of Acutus Medical, Inc. (NASDAQ:AFIB) have received an average recommendation of “Buy” from the seven research firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1 year price target among analysts that have […]
— Dakota Financial News

3D Cardiac Mapping Market in China Expected to Reach $150.59 Million by 2027 Industry Review By: Abbott Laboratories, Microport Scientific Corporation, Medtronic, Acutus Medical

Wednesday, 21 October 2020, 11:48:30
According to a new report published by Allied Market Research, titled, “China 3D Cardiac Mapping Market by application and end user: opportunity analysis and industry forecast, 2020–2027,” the China 3D cardiac mapping market was valued at $55.55 million in 2019
— OpenPR